SCHEMBL3104909

SCHEMBL3104909

COC(=O)[C@@H]1CCCN1C[C@@H](CO)NC(=O)OOCc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.48
ALDH1A1 P00352 1/20 0.45
CYP3A4 P08684 1/20 0.45
TSHR P16473 1/20 0.45
MMEL1 Q495T6 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
ADORA2A P29274 1/20 0.42
ADORA2B P29275 1/20 0.42
ADORA1 P30542 1/20 0.42
POLB P06746 1/20 0.42
KLK5 Q9Y337 1/20 0.41
ACE P12821 2/20 0.41
FKBP1A P62942 2/20 0.41
CTRB1 P17538 1/20 0.39
ADRA1D P25100 1/20 0.39
ADRA1A P35348 1/20 0.39
ADRA1B P35368 1/20 0.39
PREP P48147 2/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL371906 0.90 ALDH1A1 (0.55) LTA4HALDH1A1CYP3A4TSHRMMEL1
SCHEMBL378574 0.90 ALDH1A1 (0.55) LTA4HALDH1A1CYP3A4TSHRMMEL1
SCHEMBL6017607 0.81 ACE (0.54) ALDH1A1CYP3A4TSHRMMEL1ADORA3
SCHEMBL4044966 0.78 ALDH1A1 (0.51) LTA4HALDH1A1CYP3A4TSHRMMEL1
SCHEMBL372167 0.78 ALDH1A1 (0.51) LTA4HALDH1A1CYP3A4TSHRMMEL1
SCHEMBL18065507 0.78 MMEL1 (0.54) LTA4HALDH1A1CYP3A4TSHRMMEL1
SCHEMBL16692005 0.78 MMEL1 (0.54) LTA4HALDH1A1CYP3A4TSHRMMEL1
SCHEMBL8647455 0.77 KLK5 (0.61) LTA4HMMEL1ADORA3ADORA2AADORA2B
SCHEMBL8647459 0.77 KLK5 (0.61) LTA4HMMEL1ADORA3ADORA2AADORA2B
SCHEMBL7269454 0.77 KLK5 (0.61) LTA4HMMEL1ADORA3ADORA2AADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2210607-A1 N-[3-fluoro-4-({6-(methyloxy)-7-[(3-piperidin-1-ylpropyl)oxy]quinolin-4-yl}oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide for the treatment of cancer Exelixis Inc. (US) 2010-07-28 EP disclosed